title: Dairy components and risk factors for cardiometabolic syndrome: recent evidence and opportunities for future research.
abstract: Cardiometabolic syndrome (CMS), a cluster of metabolic abnormalities that increases the risk of cardiovascular disease (CVD) and type 2 diabetes, affects over one-third of American adults and accounts for billions of dollars in health care costs annually. Current evidence indicates an inverse association between consumption of dairy foods and risk of CMS and its related disease outcomes. Although the specific mechanism(s) underlying the beneficial effects of dairy consumption on the development of CMS, CVD, and type 2 diabetes have not been fully elucidated, there is evidence that specific components within dairy such as milkfat, vitamin D, calcium, magnesium, potassium, and whey proteins may be individually or collectively involved. Specifically, each of these dairy components has been implicated as having a neutral or beneficial effect on one or more elements of CMS, including the serum lipid profile, blood pressure, fasting glucose, and body composition. Although several mechanisms have been identified by which components in dairy may beneficially affect symptoms associated with CMS, further research is required to better understand how dairy and its components may contribute to metabolic health. The purpose of this review is to present the mechanisms by which specific dairy components modulate risk factors for CMS and identify opportunities for future research.
authors.affiliation: Dairy Research Institute, Rosemont, IL, USA.
authors.forename: Beth H
authors.initials: BH
authors.lastname: Rice
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Cifelli
authors.forename: Matthew A
authors.initials: MA
authors.lastname: Pikosky
authors.forename: Gregory D
authors.initials: GD
authors.lastname: Miller
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure; D001823:Body Composition; D002318:Cardiovascular Diseases / Q000150:complications / Q000503:physiopathology*; D003611:Dairy Products / Q000032:analysis*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000503:physiopathology; D006801:Humans; D024821:Metabolic Syndrome / Q000209:etiology / Q000503:physiopathology*; D023421:Models, Animal; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
chemical_list: D001786:Blood Glucose